Simulations Plus Signs Another Collaboration Agreement (Business Wire)

LANCASTER, Calif.----Simulations Plus, Inc. , the leading provider of simulation and modeling software for pharmaceutical discovery and development, announced today that it has signed a collaboration agreement with a top-three pharmaceutical company to extend and enhance its ADMET Predictor™ program to predict the optimum dose level that would be required for new molecules to achieve effective plasma concentrations for large batches of new molecules in early discovery.

Add to: del.icio.us | Digg